Roderick Wong - Jun 14, 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director, 10%+ Owner
Signature
/s/ Sara Turken, as attorney-in-fact
Stock symbol
RCKT
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 08:06 PM
Next filing
Jun 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +15.3K $0.00 15.3K Jun 14, 2021 Common Stock 15.3K $47.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 15,295 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.